OBJECTIVES: To examine prevalence rates and co-relates of non-medical use of prescription stimulants for attention-deficit-hyperactivity disorder (ADHD) in a university student population with respect to student demographics and academic characteristics.   METHODS: A cross-sectional research design, utilizing a convenience sampling and self-administered paper and pencil questionnaire technique, was adopted. The survey consisted of a screening tool to measure symptoms of Adult ADHD Self-Report Scale (ASRS-v1.1) in conjunction with items to measure the extent of self-reported prescription drug abuse among students. The use of prescription stimulants was profiled for students representing different schools and academic programs and reasons for the nonmedical use were documented.  RESULTS: A sample of 638 completed surveys (response rate=98.15%) was obtained with data on unauthorized use of prescription drugs. About 8.62% (N=55) of the sample reported a current and past use of drugs such as Adderall, Ritalin, Dexedrine, Concerta, Cylert at least once. Of these, 76.9% used the drugs non-medically for enhancing academic performance and 23.1% used them for increasing alertness. The illicit drug usage was higher in the age group 18-23 years (87.2%) and was greater for males (64.1%). Overall, students from pharmacy school reported highest abuse (46.2%), followed by law school (20.5%), school of professional studies (12.8%) and business school (10.3%). Generally, undergraduate students reported greater use of prescription stimulants (69.2%) compared to graduate students (30.8%). A majority (66.7%) of the students were also attending professional degree programs.  CONCLUSIONS: The current campus estimates are mostly in line with the national statistics (4.1% to 10.8%, according to the Center for Lawful Access and Abuse Deterrence, CLAAD, 2013). Misuse and abuse of prescription stimulants among students is a growing problem and largely remains unaddressed. Development of campus educational tools to prevent sharing of prescription drugs and guidelines to recognize early warning signs to curb abuse are necessary.